Authors
Latest:
Treatment-Resistant OCD: Strategies and Novel Treatment OptionsOCD is highly comorbid and warrants consideration in difficult to treat cases. Learn more here.
Latest:
Emotion and Cognitive Control: An Essential Partnership for Adaptive BehaviorDisruptions to cognitive control, as well as to emotional processes, are implicated in a wide range of psychiatric disorders.
Latest:
A Case of Clozapine and CancerWhat does cancer treatment mean for psychiatric treatment with clozapine?
Latest:
Mind-Body Resilience for Women: A Focus on DepressionHere’s why we should be paying special attention to women's depression treatment.
Latest:
Bella, Horrida Bella“In the realm of psychiatry, the therapeutic value of poetry lies in its ability to transcend the limitations of prose, offering a space for the unsayable and the ineffable.”
Latest:
The Dangers of Inhalant Use DisorderInhalant use disorder is a form of substance use disorder characterized by the intentional inhalation of volatile substances for their psychoactive effects.
Latest:
Promising Publication: The Novel Schizophrenia Treatment Gaining TractionData published in The New England Journal of Medicine shows promise for a novel schizophrenia treatment.
Latest:
COVID-19, Cognition, and Dementias: What Role Has the Pandemic Played?How does COVID-19 contribute to cognitive impairment in older adults and future cases of dementia?
Latest:
Issues in Regulating DTxWe need policies that make digital therapeutics accessible and acceptable to a broad patient audience. What barriers are there to reaching that goal?
Latest:
Incorporating Well-Being Into Child and Adolescent PsychiatryA well-being centered approach expands assessment and treatment for the child’s strengths and opportunities for positive experiences with the family.
Latest:
The Noxious Psychological Effects of Anti-LGBTQ+ Legislative Bills Sweeping Across the USThe Florida “Don’t Say Gay” bill will have a devastating effect on LGBTQ+ youth.
Latest:
Delays in Psychiatric Care: New Hampshire’s Robust ResponseNew Hampshire’s mental health system faces ongoing challenges with emergency department boarding, legal concerns over due process, and resource shortages, prompting reforms to improve patient care and access.
Latest:
Seltorexant, Major Depressive Disorder, and Insomnia: Thoughts on the New DataAndrew Krystal, MD, and Wayne Drevets, MD, share their thoughts on the recent seltorexant data presented at the 2024 ASCP Annual Meeting.
Latest:
RE104: A Novel, Fast-Acting Psychedelic for Postpartum DepressionExperts share the results from the first-in-human phase 1 study of this treatment, plus a preview of its upcoming phase 2 trial.
Latest:
RE104: A Novel, Fast-Acting Psychedelic for Postpartum DepressionExperts share the results from the first-in-human phase 1 study of this treatment, plus a preview of its upcoming phase 2 trial.
Latest:
SUDs in Women and the Importance of Tailored Treatment ApproachesWhat are the most effective approaches to SUD treatment in this unique patient population?
Latest:
Let’s Build Brains Better! Brain Science-Inspired Policies for the FutureIn order to face the rapidly changing, increasingly complex, and globally connected world, we need to focus on the importance of early brain and child development.
Latest:
Psychopathy: Insights for General PracticeWhile incarceration is the definitive “treatment” for some, psychopathy exists on a spectrum like any other mental disorder; more recent research suggests the condition is capable of responding to treatment.
Latest:
Resiliency and Posttraumatic Growth: Cultural Implications for PsychiatristsAcknowledging a patient's ability to grow and recover may help them feel more understood despite ongoing suffering.
Latest:
Adding Insult to Narcissistic Injury: Comorbidity of Narcissistic Personality Disorder and Major Depressive DisorderDiagnosing this intricate comorbidity demands a nuanced approach. Here's what you need to know.
Latest:
Zuranolone for the Treatment of Adults With Major Depressive DisorderThis randomized, placebo-controlled, phase 3 clinical trial showed that a 14-day treatment course of oral zuranolone 50 mg/day in MDD led to significantly greater improvements in depressive symptoms when compared with placebo.
Latest:
SPIRIT (Social Psychiatry Interested in Recovery from International Trauma) Voices Some Current ConcernsAll these events that occurred over the weekend bear social psychiatric weight.
Latest:
Brain Capital: An Emerging Investment OpportunityBrain Capital: a fresh approach to technologies and investing.
Latest:
Opportunities in Managing Treatment-Resistant Depression and Tardive DyskinesiaThis CME describes current strategies and recent advances in treatment.
Latest:
Physician Liability During COVID-19: What You Need to Know To Protect Your PracticeDoes the typical malpractice insurance policy cover COVID-related claims? That question and more answered.
Latest:
New-Onset Racism or Psychosis?Racism is not usually considered a psychotic symptom and therefore it is not often considered in the diagnosis of schizophrenia.
Latest:
Exploring Diagnostic Strategies in the Assessment of Mixed Affective StatesIn this CME article, examine how current DSM nosology defines the proper method of assessing a mixed-episode patient and which diagnostic labels to give them based on their presenting symptomatology.
